(USNA) USANA Health Sciences - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US90328M1071

USNA: Nutritional Supplements, Skincare Products, Food Products, Business Tools

USANA Health Sciences Inc (NYSE:USNA) is a leading developer, manufacturer, and distributor of premium nutritional supplements, personal care products, and skincare solutions, operating globally across the Asia Pacific, the Americas, and Europe. The companys product portfolio is diversified across two primary business segments: Direct Selling and Hiya Direct-To-Consumer, catering to a wide range of customer needs.

The companys product offerings include a broad spectrum of nutritional supplements, such as USANA nutritional optimizers, Essentials/CellSentials, and food products designed for healthy weight management, digestive health, and energy and hydration. Additionally, USANA provides Celavive, a comprehensive skincare regimen tailored to various skin types and ethnicities, as well as other products and tools aimed at supporting associates in building their businesses and marketing efforts.

USANAs distribution strategy encompasses multiple channels, including retail customers, subscription models, direct selling, and online sales, allowing the company to effectively reach and serve its diverse customer base. The company has also established strategic research collaborations with reputable institutions, such as Beijing University of Chinese Medicine and the National Sports Training Bureau, to drive innovation and stay at the forefront of the industry.

From a technical analysis perspective, USANAs stock price has been trending below its 200-day Simple Moving Average (SMA), indicating a potential downtrend. However, the stocks current price is above its 20-day and 50-day SMAs, suggesting a short-term uptrend. The Average True Range (ATR) indicates a moderate level of volatility. Considering the , a potential trading opportunity may arise if the stock price breaks above its 52-week high or falls below its 52-week low.

Fundamentally, USANAs market capitalization stands at $528.83M USD, with a Price-to-Earnings (P/E) ratio of 15.41 and a Forward P/E of 10.68, indicating a relatively reasonable valuation. The companys Return on Equity (RoE) is 6.63%, suggesting a moderate level of profitability. By analyzing the , it is evident that USANAs financial performance is stable, with a reasonable valuation. Combining this with the , a forecast can be made that USANAs stock price may experience a rebound if the company reports strong earnings and the overall market sentiment improves.

Based on the analysis of both and , a potential forecast for USANAs stock price is a short-term increase towards $30.00, driven by a potential breakout above its current trading range. However, a sustained uptrend may require the company to demonstrate significant improvement in its financial performance and/or a shift in market sentiment. Conversely, a decline below $23.43 may signal a further downtrend.

Additional Sources for USNA Stock

USNA Stock Overview

Market Cap in USD 529m
Sector Consumer Defensive
Industry Packaged Foods
GiC Sub-Industry Personal Care Products
IPO / Inception 1996-07-25

USNA Stock Ratings

Growth Rating -87.4
Fundamental 0.75
Dividend Rating 0.0
Rel. Strength -41.4
Analysts 3/5
Fair Price Momentum 21.03 USD
Fair Price DCF 56.88 USD

USNA Dividends

No Dividends Paid

USNA Growth Ratios

Growth Correlation 3m -66.3%
Growth Correlation 12m -94.2%
Growth Correlation 5y -88.6%
CAGR 5y -19.43%
CAGR/Max DD 5y -0.25
Sharpe Ratio 12m -0.11
Alpha -43.61
Beta 0.655
Volatility 33.63%
Current Volume 230.2k
Average Volume 20d 227.8k
What is the price of USNA stocks?
As of May 09, 2025, the stock is trading at USD 29.18 with a total of 230,210 shares traded.
Over the past week, the price has changed by +4.07%, over one month by +20.53%, over three months by -5.96% and over the past year by -35.18%.
Is USANA Health Sciences a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, USANA Health Sciences is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 0.75 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of USNA as of May 2025 is 21.03. This means that USNA is currently overvalued and has a potential downside of -27.93%.
Is USNA a buy, sell or hold?
USANA Health Sciences has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold USNA.
  • Strong Buy: 0
  • Buy: 0
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for USNA stock price target?
According to ValueRays Forecast Model, USNA USANA Health Sciences will be worth about 23.2 in May 2026. The stock is currently trading at 29.18. This means that the stock has a potential downside of -20.36%.
Issuer Forecast Upside
Wallstreet Target Price 61 109%
Analysts Target Price 51.5 76.5%
ValueRay Target Price 23.2 -20.4%